Microbiome: A New Perspective on Immunotherapy for Metastatic Tumors

Hongquan Liu; Tianqi Wang; Jitao Wu

doi:10.1002/mco2.70185

MedComm ›› 2025, Vol. 6 ›› Issue (5) : e70185 DOI: 10.1002/mco2.70185

HIGHLIGHT

Microbiome: A New Perspective on Immunotherapy for Metastatic Tumors

Author information +

History +

PDF

Cite this article

Download citation ▾

Hongquan Liu, Tianqi Wang, Jitao Wu. Microbiome: A New Perspective on Immunotherapy for Metastatic Tumors. MedComm, 2025, 6(5): e70185 DOI:10.1002/mco2.70185

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	T. W. Battaglia, I. L. Mimpen, J. J. H. Traets, et al., “A Pan-Cancer Analysis of the Microbiome in Metastatic Cancer,” Cell 187, no. 9 (2024): 2324-2335.e19.

[2]	N. Cullin, C. Azevedo Antunes, R. Straussman, C. K. Stein-Thoeringer, and E. Elinav, “Microbiome and Cancer,” Cancer Cell 39, no. 10 (2021): 1317-1341.

[3]	M. R. Fernandes, P. Aggarwal, R. G. F. Costa, A. M. Cole, and G. Trinchieri, “Targeting the Gut Microbiota for Cancer Therapy,” Nature Reviews Cancer 22, no. 12 (2022): 703-722.

[4]	D. Nejman, I. Livyatan, G. Fuks, et al., “The human Tumor Microbiome Is Composed of Tumor Type-Specific Intracellular Bacteria,” Science 368, no. 6494 (2020): 973-980.

[5]	J. L. Galeano Niño, H. Wu, K. D. LaCourse, et al., “Effect of the Intratumoral Microbiota on Spatial and Cellular Heterogeneity in Cancer,” Nature 611, no. 7937 (2022): 810-817.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.